submitter_follow_up_id,program_id,submitter_donor_id,submitter_primary_diagnosis_id,submitter_treatment_id,date_of_followup,disease_status_at_followup,relapse_type,date_of_relapse,method_of_progression_status,anatomic_site_progression_or_recurrence
FOLLOW_UP_0001,SYNTH_01,DONOR_0001,DIAG_0001,,"{'day_interval': 1883, 'month_interval': 61}",Distant progression,Distant recurrence/metastasis,"{'day_interval': 682, 'month_interval': 22}",Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0002,SYNTH_01,DONOR_0002,,TREATMENT_0003,"{'day_interval': 569, 'month_interval': 18}",No evidence of disease,Local recurrence,,Physical examination procedure (procedure)|Histopathology test (procedure),
FOLLOW_UP_0003,SYNTH_01,DONOR_0003,,,"{'day_interval': 2874, 'month_interval': 94}",Loco-regional progression,Local recurrence and distant metastasis,"{'day_interval': 1884, 'month_interval': 61}",Physical examination procedure (procedure)|Laboratory data interpretation (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0004,SYNTH_01,DONOR_0004,DIAG_0004,,"{'day_interval': 3726, 'month_interval': 122}",Loco-regional progression,Local recurrence and distant metastasis,"{'day_interval': 1075, 'month_interval': 35}",Imaging (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0005,SYNTH_01,DONOR_0005,,TREATMENT_0009,,,Biochemical progression,,Tumor marker measurement (procedure)|Imaging (procedure),
FOLLOW_UP_0006,SYNTH_01,DONOR_0006,,,"{'day_interval': 2012, 'month_interval': 66}",Partial remission,Progression (liquid tumours),,Tumor marker measurement (procedure)|Assessment of symptom control (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0007,SYNTH_01,DONOR_0007,DIAG_0007,,"{'day_interval': 2491, 'month_interval': 81}",,Biochemical progression,,Assessment of symptom control (procedure),
FOLLOW_UP_0008,SYNTH_01,DONOR_0008,,TREATMENT_0015,,Progression not otherwise specified,Local recurrence,"{'day_interval': 232, 'month_interval': 7}",Physical examination procedure (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0009,SYNTH_01,DONOR_0009,,,"{'day_interval': 4375, 'month_interval': 143}",,Distant recurrence/metastasis,,Physical examination procedure (procedure)|Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0010,SYNTH_01,DONOR_0010,DIAG_0010,,"{'day_interval': 7425, 'month_interval': 243}",Stable,Local recurrence and distant metastasis,,Laboratory data interpretation (procedure)|Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0011,SYNTH_02,DONOR_0021,,TREATMENT_0041,,Complete remission,Progression (liquid tumours),,Physical examination procedure (procedure)|Histopathology test (procedure),
FOLLOW_UP_0012,SYNTH_02,DONOR_0022,,,"{'day_interval': 10651, 'month_interval': 349}",Progression not otherwise specified,Biochemical progression,"{'day_interval': 668, 'month_interval': 21}",Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0013,SYNTH_02,DONOR_0023,DIAG_0023,,,Complete remission,Distant recurrence/metastasis,,Tumor marker measurement (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0014,SYNTH_02,DONOR_0024,,TREATMENT_0047,"{'day_interval': 647, 'month_interval': 21}",Loco-regional progression,Progression (liquid tumours),"{'day_interval': 168, 'month_interval': 5}",Laboratory data interpretation (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0015,SYNTH_02,DONOR_0025,,,"{'day_interval': 1414, 'month_interval': 46}",Progression not otherwise specified,Distant recurrence/metastasis,,Physical examination procedure (procedure)|Imaging (procedure),
FOLLOW_UP_0016,SYNTH_02,DONOR_0026,DIAG_0026,,"{'day_interval': 7097, 'month_interval': 233}",No evidence of disease,Distant recurrence/metastasis,,Imaging (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0017,SYNTH_02,DONOR_0027,,TREATMENT_0053,"{'day_interval': 449, 'month_interval': 14}",Distant progression,Local recurrence,,Tumor marker measurement (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0018,SYNTH_02,DONOR_0028,,,"{'day_interval': 10966, 'month_interval': 360}",Distant progression,Local recurrence and distant metastasis,"{'day_interval': 3144, 'month_interval': 103}",Tumor marker measurement (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0019,SYNTH_02,DONOR_0029,DIAG_0029,,,Partial remission,Progression (liquid tumours),,Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0020,SYNTH_02,DONOR_0030,,TREATMENT_0059,,Stable,Distant recurrence/metastasis,,Assessment of symptom control (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0021,SYNTH_03,DONOR_0041,,,"{'day_interval': 3411, 'month_interval': 112}",Loco-regional progression,Biochemical progression,"{'day_interval': 1229, 'month_interval': 40}",Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_0022,SYNTH_03,DONOR_0042,DIAG_0042,,,Loco-regional progression,Local recurrence,"{'day_interval': 452, 'month_interval': 14}",Physical examination procedure (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0023,SYNTH_03,DONOR_0043,,TREATMENT_0085,"{'day_interval': 716, 'month_interval': 23}",No evidence of disease,Progression (liquid tumours),,Assessment of symptom control (procedure)|Histopathology test (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0024,SYNTH_03,DONOR_0044,,,"{'day_interval': 9614, 'month_interval': 315}",Stable,Distant recurrence/metastasis,,Imaging (procedure)|Laboratory data interpretation (procedure)|Histopathology test (procedure),
FOLLOW_UP_0025,SYNTH_03,DONOR_0045,DIAG_0045,,,Loco-regional progression,Local recurrence and distant metastasis,"{'day_interval': 490, 'month_interval': 16}",Histopathology test (procedure),
FOLLOW_UP_0026,SYNTH_03,DONOR_0046,,TREATMENT_0091,"{'day_interval': 767, 'month_interval': 25}",,Distant recurrence/metastasis,,Physical examination procedure (procedure)|Imaging (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0027,SYNTH_03,DONOR_0047,,,"{'day_interval': 1799, 'month_interval': 59}",Complete remission,Biochemical progression,,Imaging (procedure)|Physical examination procedure (procedure),
FOLLOW_UP_0028,SYNTH_03,DONOR_0048,DIAG_0048,,"{'day_interval': 1713, 'month_interval': 56}",Complete remission,Local recurrence and distant metastasis,,Tumor marker measurement (procedure)|Physical examination procedure (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_0029,SYNTH_03,DONOR_0049,,TREATMENT_0097,"{'day_interval': 640, 'month_interval': 21}",,Progression (liquid tumours),,Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0030,SYNTH_03,DONOR_0050,,,,Loco-regional progression,Distant recurrence/metastasis,"{'day_interval': 351, 'month_interval': 11}",Laboratory data interpretation (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0031,SYNTH_04,DONOR_0061,DIAG_0061,,"{'day_interval': 1631, 'month_interval': 53}",Loco-regional progression,Local recurrence and distant metastasis,"{'day_interval': 993, 'month_interval': 32}",Histopathology test (procedure)|Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0032,SYNTH_04,DONOR_0062,,TREATMENT_0123,,,Distant recurrence/metastasis,,Histopathology test (procedure),
FOLLOW_UP_0033,SYNTH_04,DONOR_0063,,,,Relapse or recurrence,Local recurrence,,Assessment of symptom control (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0034,SYNTH_04,DONOR_0064,DIAG_0064,,"{'day_interval': 3446, 'month_interval': 113}",Complete remission,Local recurrence and distant metastasis,,Physical examination procedure (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0035,SYNTH_04,DONOR_0065,,TREATMENT_0129,"{'day_interval': 1033, 'month_interval': 33}",Progression not otherwise specified,Distant recurrence/metastasis,"{'day_interval': 757, 'month_interval': 24}",Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_0036,SYNTH_04,DONOR_0066,,,"{'day_interval': 3426, 'month_interval': 112}",Progression not otherwise specified,Local recurrence,"{'day_interval': 2209, 'month_interval': 72}",Histopathology test (procedure)|Imaging (procedure),
FOLLOW_UP_0037,SYNTH_04,DONOR_0067,DIAG_0067,,"{'day_interval': 2560, 'month_interval': 84}",Loco-regional progression,Local recurrence and distant metastasis,"{'day_interval': 2135, 'month_interval': 70}",Physical examination procedure (procedure)|Histopathology test (procedure),
FOLLOW_UP_0038,SYNTH_04,DONOR_0068,,TREATMENT_0135,"{'day_interval': 969, 'month_interval': 31}",Relapse or recurrence,Progression (liquid tumours),,Imaging (procedure)|Tumor marker measurement (procedure),
FOLLOW_UP_0039,SYNTH_04,DONOR_0069,,,"{'day_interval': 5576, 'month_interval': 183}",,Distant recurrence/metastasis,,Laboratory data interpretation (procedure)|Imaging (procedure),
FOLLOW_UP_0040,SYNTH_04,DONOR_0070,DIAG_0070,,"{'day_interval': 5940, 'month_interval': 195}",Partial remission,Biochemical progression,,Tumor marker measurement (procedure)|Imaging (procedure)|Laboratory data interpretation (procedure),
FOLLOW_UP_NULL_0001,SYNTH_01,DONOR_NULL_0001,,TREATMENT_NULL_0001,,,,,,
FOLLOW_UP_NULL_0002,SYNTH_01,DONOR_NULL_0002,,,"{'day_interval': 1038, 'month_interval': 34}",,,,,
FOLLOW_UP_ALL_0001,SYNTH_01,DONOR_ALL_0001,DIAG_ALL_0001,,"{'day_interval': 6189, 'month_interval': 203}",,Progression (liquid tumours),,Laboratory data interpretation (procedure)|Histopathology test (procedure)|Assessment of symptom control (procedure),
FOLLOW_UP_ALL_0002,SYNTH_01,DONOR_ALL_0002,,TREATMENT_ALL_0003,"{'day_interval': 912, 'month_interval': 29}",,Local recurrence and distant metastasis,,Assessment of symptom control (procedure)|Tumor marker measurement (procedure)|Laboratory data interpretation (procedure),
